2012
Implementing Provider‐based Sampling for the National Children's Study: Opportunities and Challenges
Belanger K, Buka S, Cherry DC, Dudley DJ, Elliott MR, Hale DE, Hertz‐Picciotto I, Illuzzi JL, Paneth N, Robbins JM, Triche EW, Bracken MB. Implementing Provider‐based Sampling for the National Children's Study: Opportunities and Challenges. Paediatric And Perinatal Epidemiology 2012, 27: 20-26. PMID: 23215706, DOI: 10.1111/ppe.12005.Peer-Reviewed Original ResearchConceptsNational Children's StudyProvider-based samplingChildren's StudyNational cohort studyPrenatal care providersNational probability sampleType of providerProbability sampleCohort studyPrenatal careCare providersChild healthProvider groupsAge 21Risk estimatesPrimary sampling unitsWomenBirthProvidersHealthSampling frameSecondary sampling unitsPregnancyNumber of strategiesUtero
1990
Conception delay after oral contraceptive use: the effect of estrogen dose**Supported by grant HD 11357 and HD 16282 from the National Institutes for Child Health and Human Development and by grant DA 05484 from the National Institute for Drug Abuse, Bethesda, Maryland.
Bracken M, Hellenbrand K, Holford T. Conception delay after oral contraceptive use: the effect of estrogen dose**Supported by grant HD 11357 and HD 16282 from the National Institutes for Child Health and Human Development and by grant DA 05484 from the National Institute for Drug Abuse, Bethesda, Maryland. Fertility And Sterility 1990, 53: 21-27. PMID: 2295345, DOI: 10.1016/s0015-0282(16)53210-5.Peer-Reviewed Original ResearchConceptsOral contraceptive useContraceptive useFormer oral contraceptive usersConception delayFormer OC usersLower estrogen dosesOral contraceptive usersEffects of estrogenNational InstituteMethod of contraceptionEstrogen doseOC discontinuationEstrogen dosesOral contraceptionOC usersContraceptive usersChild healthProbability of conceptionHigh dosesDrug abuseMean timeDiscontinuationSignificant delaySignificant reductionEstrogen